Compare Tata Nifty MidSmall Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.07
2.09
NAV
₹14.93
₹47.06
Fund Started
08 Apr 2024
25 Jun 2018
Fund Size
₹182.18 Cr
₹6624.58 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 15 days.
1 Year
11.04%
6.41%
3 Year
-
24.51%
5 Year
-
15.50%
Equity
100.06%
96.05%
Cash
-0.06%
3.95%
Top 10 Holdings
Laurus Labs Ltd. | 9.36% |
Lupin Ltd. | 9.30% |
Fortis Healthcare Ltd. | 7.90% |
Aurobindo Pharma Ltd. | 6.99% |
Glenmark Pharmaceuticals Ltd. | 5.26% |
Alkem Laboratories Ltd. | 5.17% |
Biocon Ltd. | 4.73% |
Mankind Pharma Ltd. | 4.56% |
Ipca Laboratories Ltd. | 3.74% |
Krishna Institute of Medical Sciences Ltd | 3.19% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
08 Apr 2024
25 Jun 2018
